title: Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial.
authors.forename: Ron
authors.initials: R
authors.lastname: Keren
authors.forename: Myra
authors.initials: M
authors.lastname: Carpenter
authors.forename: Saul
authors.initials: S
authors.lastname: Greenfield
authors.forename: Alejandro
authors.initials: A
authors.lastname: Hoberman
authors.forename: Ranjiv
authors.initials: R
authors.lastname: Mathews
authors.forename: Tej
authors.initials: T
authors.lastname: Mattoo
authors.forename: Russell
authors.initials: R
authors.lastname: Chesney
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage; D019072:Antibiotic Prophylaxis; D002648:Child; D002675:Child, Preschool; D002921:Cicatrix / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007223:Infant; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008297:Male; D011379:Prognosis; D011704:Pyelonephritis / Q000209:etiology / Q000517:prevention & control*; D012016:Reference Values; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D016482:Urinalysis; D014718:Vesico-Ureteral Reflux / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary